Trials / Completed
CompletedNCT00546182
Simvastatin Reduces Adiponectin Levels and Insulin Sensitivity
Phase 4 Study of Simvastatin That Affects Insulin Sensitivity
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- —
- Sponsor
- Gachon University Gil Medical Center · Academic / Other
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
We hypothesized simvastatin may reduce adiponectin levels and insulin sensitivity in overweight hypercholesterolemic patients.
Conditions
Timeline
- Start date
- 2004-01-01
- First posted
- 2007-10-18
- Last updated
- 2007-10-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00546182. Inclusion in this directory is not an endorsement.